Recipients establish the benchmark for scientific advancements that enhance human health
NEW YORK, June 21, 2024 /PRNewswire/ -- The Galien Foundation, the premier global institution dedicated to honoring innovators in life sciences, today announced the winners for the 2024 International Prix Galien Awards and Prix Galien Italy Awards, hosted on June 20 at the Parco dei Principi Grand Hotel, in Rome.
"We are honored to host the Prix Galien Italy and International Prix Galien in tandem, bringing together the most forward-thinking innovators across the life sciences here in Italy, and across the world," said Pr. Pier Luigi Canonico, Chair of the Prix Galien Italy and International Prix Galien Awards Committee. "It is thrilling to welcome those who have excelled in the pursuit of scientific advancement to the global stage, and we look forward to seeing their continued success as Prix Galien alumni."
Awards for "Advanced Therapy Medicinal Products," "Best Biological Drug," "Best Chemical Synthesis Drug," "Best Chemical-Biotechnological Drug," "Best Orphan Drug," "Best Real-World Evidence," and "Best Vaccine" were presented to industry leaders dedicated to innovation that improves the human condition. In addition to awarding this year's Prix Galien Italy winners, the International Prix Galien Award winners were selected from laureates who were previously awarded a national Prix Galien in 2022 and 2023. Winners were selected across the following categories: "Best Biotechnology Product," "Best Digital Health Solution," "Best Medical Technology," "Best Pharmaceutical Product", and "Best Vaccine."
"The Galien Foundation is dedicated to uplifting talent in the life sciences industries and rewarding landmark achievements across a vast range of complex and challenging medical fields. As we kick off the summer season, the Prix Galien Italy and International Prix Galien provide us with an opportunity to celebrate a summer of therapeutic innovation," said Bruno Cohen, Chairman of The Galien Foundation. "We extend our utmost gratitude to our 2024 International Prix Galien and Prix Galien Italy winners who have proven that continued perseverance, dedication, and innovation for the future of healthcare is paving the way forward for us all."
The International Prix Galien Awards is organized once every two years, inviting candidates who have previously won a National Prix Galien award during the two years preceding the International Awards ceremony. The next International Prix Galien will be hosted in March 2026, in New Delhi.
The 2024 International Prix Galien Award Winners
Best Biotechnology Product
Novartis
Zolgensma
Best Digital Health Solution
behold.ai
red.dot
Exscientia
Exscientia's end-to-end AI driven precision medicine platform
Best Medical Technology
Ziwig
Ziwig Endotest
Best Pharmaceutical Product
Eli Lilly
Mounjaro
Best Product for Orphan/Rare Diseases
Pierre Fabre Laboratories
EBVALLO
Vertex
TRIKAFTA
International Prix Galien Awards Committee
Italy – PR PIER LUIGI CANONICO Committee Chair, Professor Emeritus of Pharmacology, Università del Piemonte Orientale Amedeo Avogadro
Africa – PR AWA MARIE COLL SECK Chair, Galien Africa; Former Senior Minister to the President of the Republic of Senegal, Former Minister of Health
Belgium – Luxembourg – PR JAN DE HOON Professor in Pharmacology / Clinical Pharmacology, UPC KULeuven
Canada – PR ERNESTO L. SCHIFFRIN Physician-in-Chief, Department of Medicine, Jewish General Hospital; Director, Hypertension and Vascular Research Unit, Lady Davis Institute for Medical Research; Distinguished James McGill Professor and Associate Chair, Department of Medicine, McGill University
France – Dr ANNICK TIBI Head of Clinical Trials Department, AGEPS, AP-HP; Associate Professor – Head of UP "Pharmaceutical Development and Innovation," Faculty of Pharmacy, University of Paris
Germany – PR ERLAND ERDMANN Professor Emeritus, University of Cologne | UOC - Division of Cardiology, Pneumology, Angiology and Intensive Care, Köln
Greece – PR GEORGES P. CHROUSOS Professor, School of Medicine, National and Kapodistrian School of Athens
India – PR MANJU SHARMA Former Secretary to the Government of India, Department of Biotechnology; Chair New Initiative, NASI, Allahabad
The Netherlands – PR DR KOOS BURGGRAAF CEO, Centre for Human Drug Research; Professor, Division of Pharmacology Leiden Academic Centre for Drug Research, University of Leiden
PR DR LISETE VAN GEMERT-PIJNEN Full Professor Persuasive Health Technology, University of Twente, and Visiting Professor, University of Waterloo
Poland – PR CEZARY SZCZYLIK Polish Professor of Medical Science Specializing in Oncology, Hematology and Internal Diseases
Switzerland – PR CHRISTOPH RENNER Professor of Hematology - General Internal Medicine - Medical Oncology
United Kingdom– PR SIR MUNIR PIRMOHAMED David Weatherall Chair of Medicine, University of Liverpool; NHS Chair of Pharmacogenetics
United States of America – PR MICHAEL ROSENBLATT Former Dean of Tufts University School of Medicine, Former Chief Medical Officer of Merck & Co. Inc.
The 2024 Prix Galien Italy Award Winners
Best Chemical Synthesis Drug
SERVIER
IVOSIDENIB (TIBSOVO)
Best Biological Drug
ROCHE
GLOFITAMAB (COLUMVI)
Best Orphan Drug
AMGEN
BLINATUMOMAB
Best Vaccine
MSD
ANTI-PNEUMOCOCCAL VACCINE (VAXNEUVANCE)
Advanced Therapy Medicinal Products
PIERRE FABRE
TABELECLEUCEL
Best Chemical- Biotechnological Drug
DAIICHI SANKYO / ASTRA ZENECA
TRASTUZUMAB DERUXTECAN (ENHERTU)
Best Real-World Evidence
MSD
PEMBROLIZUMAB
The 2024 Prix Galien Italy Special Mentions
Special Mention for Chemical Synthesis Drug
ASTRA ZENECA
DAPAGLIFOZIN (FORXIGA)
Special Mention for Orphan Drug
IMMUNOCORE
TEBENTAFUSP (KIMMTRAK)
Prix Galien Italy Awards Committee
PR PIER LUIGI CANONICO Committee Chair, Professor Emeritus of Pharmacology, Università del Piemonte Orientale Amedeo Avogadro
PR ALBERTO CORSINI Università degli Studi di Milano
PR ANNAMARIA DE LUCA Università degli Studi di Bari Aldo Moro
PR MAURIZIO D'INCALCI Humanitas University Milano
PR TULLIO FLORIO Università degli Studi di Genova
PR MARIAGRAZIA GRILLI Università degli Studi del Piemonte Orientale
PR CARLO RICCARDI Università degli Studi di Perugia
PR MARIA ANGELA SORTINO Università di Catania
PR MAURIZIO TAGLIALATELA Università Vanvitelli di Napoli
PR LUIGIA TRABACE Università degli Studi di Foggia
PR STEFANO VELLA Università Cattolica del Sacro Cuore, Roma
About The Galien Foundation
The Galien Foundation fosters, recognizes, and rewards excellence in scientific innovation to improve the state of human health. Our vision is to be the catalyst for the development of the next generation of innovative treatments and technologies that will impact the state of medical practice and save lives. The late Professor Elie Wiesel, 1986 Peace Nobel Laureate, is The Honorary Founding President of The Galien Foundation
The Foundation oversees and directs activities in the US for the Prix Galien, an international awards program dedicated to progress through innovative medicines development, with chapters in 14 countries, Africa and an inaugural chapter established in India in 2024. The Prix Galien was created in 1970 by Roland Mehl in honor of Galen, the father of medical science and modern pharmacology. Worldwide, the Prix Galien is regarded as the equivalent of the Nobel Prize in biopharmaceutical research.
For more information, visit .
Follow the Foundation on social media:
Media Contact: Kara Bradley Finn Partners [email protected] +1 646-213-7243
SOURCE The Galien Foundation
受取人は、人間の健康を向上させる科学の進歩の基準を確立する必要があります。
2024年6月20日にローマのParco dei Principi Grand Hotelで開催された2024年国際Prix Galien賞およびPrix Galien Italy賞の受賞者が発表され、グローバルなライフサイエンスの革新者を称えるために奉献された最高のグローバルな機関であるGalien FoundationがPRNewswireを発表しました。
「Galien Foundationは、イタリアと世界中のライフサイエンスの最も先進的な革新者を結集し、Prix Galien ItalyとInternational Prix Galienをタンデムで開催することを誇りに思っています。科学の前進に優れた人々をグローバルなステージに迎えることは、Prix Galienの同窓生としての継続的な成功を見ることができることにわくわくしています。」とPrix Galien ItalyおよびInternational Prix Galien Awards Committeeの委員長であるPr. Pier Luigi Canonicoは述べています。
「先進的治療薬製品」「最高のバイオロジック薬」「最高の化学合成薬」「最高の化学-バイオテクノロジー薬」「最高の奇病薬」「最高の現実世界の証拠」「最高のワクチン」の受賞者が発表されました。人間の状態を改善する革新に専念する業界リーダーに授与されます。今年のPrix Galien Italyの受賞者に加えて、International Prix Galien Awardの受賞者は、2022年と2023年に国内賞で受賞した受賞者から選ばれました。受賞者は、次のカテゴリーで選ばれました。 「最高のバイオテクノロジー製品」、「最高のデジタルヘルスソリューション」、「最高の医療技術」、「最高の医薬品製品」、「最高のワクチン」。
「Galien Foundationは、ライフサイエンス産業の才能を高め、複雑で困難な医療分野の幅広い範囲での画期的な成果を報酬として授与することに捧げられています。夏のシーズンの幕開けに、Prix Galien ItalyおよびInternational Prix Galienは、治療上の革新の夏を祝う機会を提供します。」とGalien Foundationの議長であるBruno Cohenは述べています。「継続的な粘り強さ、献身、そして医療の未来のための革新が私たち全員のための道を切り拓いていることを証明した2024年のInternational Prix GalienおよびPrix Galien Italyの受賞者に最大の感謝を表します。」
国際Prix Galien Awardsは、2年ごとに開催され、国際賞の授賞式の前2年間に国内Prix Galien賞を受賞した候補者を招待します。次回のInternational Prix Galienは、2026年3月にニューデリーで開催されます。
2024年国際Prix Galien賞受賞者
最高のバイオテクノロジー製品
Novartis
Zolgensma
最高のデジタルヘルスソリューション
behold.ai
red.dot
Exscientia
Exscientiaのエンド・トゥ・エンドの人工知能による精密医療 Best Medical Technology プラットフォーム
オーストラリアでは、moomooの投資商品及びサービスはMoomoo Securities Australia Limitedによって提供され、オーストラリア証券投資委員会(ASIC)の管理を受けております(AFSL No. 224663)。「金融サービスガイド」、「利用規約」、「プライバシーポリシー」などの詳細は、Moomoo Securities Australia Limitedのウェブサイトhttps://www.moomoo.com/auでご確認いただけます。
オーストラリアでは、moomooの投資商品及びサービスはMoomoo Securities Australia Limitedによって提供され、オーストラリア証券投資委員会(ASIC)の管理を受けております(AFSL No. 224663)。「金融サービスガイド」、「利用規約」、「プライバシーポリシー」などの詳細は、Moomoo Securities Australia Limitedのウェブサイトhttps://www.moomoo.com/auでご確認いただけます。